Evidence map›Paper›PMID 42009847›Full record

ArticleLasers in medical science2026

In search for optimal schedule during long term treatment of port wine birthmarks - data from single center retrospective cohort study with a small prospective extension.

Michal Paprocki, Anna Mataczyńska, Jan Szczękulski, Julia Sieczych, Marcin Ambroziak, Bartlomiej Kwiek

Abstract read
In one paragraph

Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michal PaprockiMedical Faculty, Uczelnia Łazarskiego, Warsaw, Poland.
Anna MataczyńskaMedical Faculty, Uczelnia Łazarskiego, Warsaw, Poland.
Jan SzczękulskiUniversity of California, San Diego, USA.
Julia SieczychMedical Faculty, Uczelnia Łazarskiego, Warsaw, Poland.
Marcin AmbroziakMedical Faculty, Uczelnia Łazarskiego, Warsaw, Poland.ORCID http://orcid.org/0009-0004-0312-2166
Bartlomiej KwiekMedical Faculty, Uczelnia Łazarskiego, Warsaw, Poland. kwiek@klinikaambroziak.pl.ORCID http://orcid.org/0000-0002-0090-8444

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of Port-wine birthmarks (PWB) requires multiple laser sessions. This study aims to determine the optimal long-term approach for PWB treatment using a 532 nm large spot laser. A retrospective analysis was conducted on fifty-five Caucasian patients, aged 6 to 59, who underwent total number of 412 sessions with interval between sessions varied from 16 to1867 days with 3D imaging assessed changes in lesion area and color before and after treatment. The median maximal improvement (GCEmax) achieved during the series of laser treatments was 63.61%. The first two laser procedures had a median maximal improvement of 31.19%, while the first 5,10,15 and 20 laser procedures had 49.84%, 58.01%, 60.13%, and 60.17%, respectively. Patients who stopped treatment for more than 180 days exhibited a worsening of the GCEmax that gradually increased over time reaching 34,7% for the brakes longer than 270 days. Additional laser sessions reversed this decline. Our findings suggest that the effectiveness of treating port wine birthmarks with large spot 532 nm laser plateaus on average after nine laser sessions. Untreated birthmarks tend to worsen over time loosing up to the third of the initial effect and worsening is evident 6 months from the last treatment. In order to avoid it, maintenance treatment should be encouraged after reaching plateau.

Indexed as

Laser TherapyPort-Wine StainAdolescentAdultChildFemaleHumansMaleMiddle AgedProspective StudiesRetrospective StudiesTime FactorsTreatment OutcomeYoung AdultLaser 532 nmLaser treatmentPort-wine birthmarksPort-wine stains

Identifiers

PMID42009847
PMCPMC13095918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.